Suppr超能文献

[李式导管在心脏再同步治疗植入中的作用]

[Effect of Li's catheter in the cardiac resynchronization therapy implantation].

作者信息

He J S, Duan J B, Li S C, Wang L, Li D, Ze F, Wu C C, Zhou X, Yuan C Z, Li X B

机构信息

Electrophysiology Lab, Department of Cardiology, Peking University People's Hospital, Beijing 100044, China.

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 2022 Aug 24;50(8):799-804. doi: 10.3760/cma.j.cn112148-20220309-00168.

Abstract

To evaluate the effect of Li's catheter in cardiac resynchronization therapy (CRT) implantation. This study was a retrospective cohort study. Patients with indications for CRT implantation who visited the Department of Cardiology, Peking University People's Hospital from January 1, 2016 to January 1, 2022 were enrolled. Patients were divided into Li's catheter group (CRT implantation with Li's catheter) and control group (CRT implantation with the traditional method). The general clinical data of the patients were obtained through the electronic medical record system. Li's catheter is a new type of coronary sinus angiography balloon catheter independently developed by Dr. Li Xuebin (patent number: 201320413174.1). The primary outcome was the success rate of CRT device implantation, and the secondary outcomes included efficacy and safety parameters. Efficacy indicators included operation time, coronary sinus angiography time, left ventricular lead implantation time, X-ray exposure time, left ventricular lead threshold, and diaphragm stimulation. Safety outcomes included incidence of coronary sinus dissection, cardiac tamponade, and pericardial effusion. A total of 170 patients were enrolled in this study, including 90 in Li's catheter group and 80 in control group. Age, male proportion of patients, proportion of patients with ischemic cardiomyopathy, hypertension, diabetes mellitus, chronic renal insufficiency, New York Heart Association (NYHA) functional classification, left ventricular ejection fraction, left ventricular end-diastolic diameter, proportion of left bundle branch block, and preoperative QRS wave width were similar between the two groups (all >0.05). In Li's catheter group, 34 cases (37.8%) implanted with CRT defibrillators, and 28 cases (35.0%) implanted with CRT defibrillators in control group, the difference was not statistically significant (=0.710). The success rate of CRT device implantation in Li's catheter group was 100% (90/90), which was significantly higher than that in control group (93.8%, 75/80, =0.023).The operation time was 57.0 (52.0, 62.3) minutes, the time to complete coronary sinus angiography was 8.0 (6.0, 9.0) minutes, and the time of left ventricular electrode implantation was 8.0 (7.0, 9.0) minutes in Li's catheter group, and was 91.3 (86.3, 97.0), 18.0 (16.0, 20.0), 25.0 (22.0, 27.7) minutes respectively in control group, all significantly shorter in Li's catheter group (all <0.05). The exposure time of X-ray was 15.0 (14.0, 17.0) minutes in Li's catheter group, which was also significantly shorter than that in control group (32.5 (29.0, 36.0) minutes, <0.001). There was no coronary sinus dissection and cardiac tamponade in Li's catheter group, and 1 patient (1.1%) had diaphragmatic stimulation in Li's catheter group. In control group, 6 patients (6.7%) had coronary sinus dissection, and 1 patient (1.1%) developed pericardial effusion, and 3 patients (3.3%) had diaphragmatic stimulation. The incidence of coronary sinus dissection in Li's catheter group was significantly lower than that in control group (=0.011). The postoperative left ventricular thresholds in Li's catheter group and control group were similar (1.80 (1.60, 2.38) V/0.5 ms vs. 1.80 (1.60, 2.40) V/0.5 ms, =0.120). Use of Li's catheter is associated with higher success rate of CRT implantation, short time of coronary sinus angiography and left ventricular electrode implantation, reduction of intraoperative X-ray exposure, and lower incidence of coronary vein dissection in this patient cohort.

摘要

评估李氏导管在心脏再同步治疗(CRT)植入中的效果。本研究为回顾性队列研究。纳入2016年1月1日至2022年1月1日就诊于北京大学人民医院心内科且有CRT植入指征的患者。患者分为李氏导管组(采用李氏导管进行CRT植入)和对照组(采用传统方法进行CRT植入)。通过电子病历系统获取患者的一般临床资料。李氏导管是李学斌博士自主研发的新型冠状静脉窦造影球囊导管(专利号:201320413174.1)。主要结局为CRT装置植入成功率,次要结局包括疗效和安全性参数。疗效指标包括手术时间、冠状静脉窦造影时间、左心室导线植入时间、X线暴露时间、左心室导线阈值及膈肌刺激情况。安全性结局包括冠状静脉窦夹层、心脏压塞及心包积液发生率。本研究共纳入170例患者,其中李氏导管组90例,对照组80例。两组患者的年龄、男性比例、缺血性心肌病患者比例、高血压、糖尿病、慢性肾功能不全、纽约心脏协会(NYHA)功能分级、左心室射血分数、左心室舒张末期内径、左束支传导阻滞比例及术前QRS波宽度相似(均>0.05)。李氏导管组34例(37.8%)植入CRT除颤器,对照组28例(35.0%)植入CRT除颤器,差异无统计学意义(P=0.710)。李氏导管组CRT装置植入成功率为100%(90/90),显著高于对照组(93.8%,75/80,P=0.023)。李氏导管组手术时间为57.0(52.0,62.3)分钟,完成冠状静脉窦造影时间为8.0(6.0,9.0)分钟,左心室电极植入时间为8.0(7.0,9.0)分钟,对照组分别为91.3(86.3,97.0)、18.0(16.0,20.0)、25.0(22.0,27.7)分钟,李氏导管组均显著短于对照组(均<0.05)。李氏导管组X线暴露时间为15.0(14.0,17.0)分钟,也显著短于对照组(32.5(29.0,36.0)分钟,P<0.001)。李氏导管组无冠状静脉窦夹层和心脏压塞发生,李氏导管组1例患者(1.1%)出现膈肌刺激。对照组6例患者(6.7%)发生冠状静脉窦夹层,1例患者(1.1%)发生心包积液,3例患者(3.3%)出现膈肌刺激。李氏导管组冠状静脉窦夹层发生率显著低于对照组(P=0.011)。李氏导管组和对照组术后左心室阈值相似(1.80(1.60,2.38)V/0.5 ms对1.80(1.60,2.40)V/0.5 ms,P=0.120)。在该患者队列中,使用李氏导管与CRT植入成功率更高、冠状静脉窦造影和左心室电极植入时间短、术中X线暴露减少及冠状静脉夹层发生率降低相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验